Screener
Orchestra BioMed Holdings, Inc. OBIO Q1 2025 Annual earnings
Reported April 2, 2025 · Before market open
Revenue$253.0KMiss by $269.3K
EPS-$0.43In line
Revenue estimate$522.3K
EPS estimate-$0.43
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$128.0K
EPS estimate-$0.40
Versus estimates
Revenue
FAQ
- When did Orchestra BioMed Holdings, Inc. report Q1 2025 earnings?
- Orchestra BioMed Holdings, Inc. (OBIO) reported Q1 2025 earnings on April 2, 2025 before market open.
- What were Orchestra BioMed Holdings, Inc.'s Q1 2025 revenue and EPS?
- Orchestra BioMed Holdings, Inc. reported revenue of $253.0K and eps of $-0.43 for Q1 2025.
- Did Orchestra BioMed Holdings, Inc. beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $522.3K by $269.3K. EPS beat the consensus estimate of $-0.43 by $0.00.
- How did Orchestra BioMed Holdings, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 59.2% from $620.0K a year earlier and eps declined 13.2% from $-0.38.
- Where can I find Orchestra BioMed Holdings, Inc.'s Q1 2025 SEC filings?
- You can read the 10-K periodic report (0001558370-25-004161) directly on SEC EDGAR. The filing index links above go to sec.gov.
